SCHEMBL3826111

SCHEMBL3826111

Brc1cccc(-c2cnc3ccccc3c2)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BIRC5 O15392 1/20 0.59
▸ PDGFRB P09619 5/20 0.51
▸ PDGFRA P16234 4/20 0.51
▸ CYP2A6 P11509 1/20 0.49
▸ NISCH Q9Y2I1 1/20 0.48
▸ PIK3CD O00329 2/20 0.46
▸ PIK3CA P42336 2/20 0.46
▸ MAP4K4 O95819 2/20 0.46
▸ CSNK1G2 P78368 2/20 0.46
▸ CLK4 Q9HAZ1 2/20 0.46
▸ MKNK2 Q9HBH9 2/20 0.46
▸ MAP4K5 Q9Y4K4 1/20 0.46
▸ TOP2A P11388 1/20 0.46
▸ TOP2B Q02880 1/20 0.46
▸ CYP1A2 P05177 1/20 0.44
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ TRPV3 Q8NET8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31220211 0.80 CYP1A2 (0.53) BIRC5PDGFRBPDGFRACYP2A6NISCH
SCHEMBL16512107 0.80 CYP1A2 (0.53) BIRC5PDGFRBPDGFRACYP2A6NISCH
SCHEMBL32667946 0.78 PDGFRB (0.77) BIRC5PDGFRBPDGFRACYP2A6NISCH
SCHEMBL2772360 0.78 PDGFRB (0.77) BIRC5PDGFRBPDGFRACYP2A6NISCH
SCHEMBL3823001 0.77 BIRC5 (0.65) BIRC5PDGFRBPDGFRACYP2A6NISCH
SCHEMBL18812500 0.77 PDGFRB (0.61) BIRC5PDGFRBPDGFRACYP2A6NISCH
SCHEMBL29419045 0.77 PDGFRB (0.56) BIRC5PDGFRBPDGFRACYP2A6NISCH
SCHEMBL2681535 0.77 PDGFRB (0.56) BIRC5PDGFRBPDGFRACYP2A6NISCH
SCHEMBL3822952 0.77 BIRC5 (0.59) BIRC5PDGFRBPDGFRACYP2A6NISCH
SCHEMBL19721615 0.75 NPC1 (0.58) BIRC5PDGFRBPDGFRACYP2A6NISCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367220-B2 Anthracene-based compound and organic light emitting device employing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-02-05 — — US disclosed
US-8367219-B2 Anthracene-based compound and organic light emitting device employing the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-02-05 — — US disclosed
CN-101570536-A Anthracene-based compound and organic light emitting device employing the same SAMSUNG ELECTRONICS CO LTD (KR) 2009-11-04 — — CN disclosed
US-20090166670-A1 Anthracene-based compound and organic light emitting device employing the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-07-02 — — US disclosed
EP-2055702-A1 Anthracene-based compound and organic light emitting device employing the same Samsung Electronics Co., Ltd. (KR) 2009-05-06 — — EP disclosed
US-20090108746-A1 Anthracene-based compound and organic light emitting device employing the same SAMSUNG DISPLAY CO., LTD. (KR) 2009-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090166670-A1 Anthracene-based compound and organic light emitting device employing the same CCNL2, CRY2, ATXN2L BIRC5 283/4885PDGFRB 4497/4885PDGFRA 4542/4885
US-20090108746-A1 Anthracene-based compound and organic light emitting device employing the same CCNL2, CRY2, ATXN2L BIRC5 283/4885PDGFRB 4497/4885PDGFRA 4542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback